Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease

International Journal of Molecular Sciences

Volumn 12, Issue 9, 2011, Pages 6281-6292

  Zanusso, Gianluigi ^a   Fiorini, Michele ^a   Ferrari, Sergio ^a   Gajofatto, Alberto ^a   Cagnin, Annachiara ^b   Galassi, Andrea ^c   Richelli, Silvia ^a   Monaco, Salvatore ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c San Bortolo General Hospital   (Italy)

Author keywords

14 3 3 protein; Amyloid beta peptide; Sporadic creutzfeldt jakob disease; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; PROTEIN 14 3 3; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRION; PRNP PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE MARKER; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PREDICTIVE VALUE; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; RELIABILITY; SENSITIVITY AND SPECIFICITY; SPORADIC CREUTZFELDT JAKOB DISEASE; CEREBROSPINAL FLUID; CONTRAINDICATIONS; CREUTZFELDT-JAKOB SYNDROME; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PHOSPHORYLATION; PRION; VERY ELDERLY;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; CREUTZFELDT-JAKOB SYNDROME; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; MUTATION; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; PRIONS; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 80053195298     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12096281     Document Type: Article

References (27)

1. Monaco, S.; Zanusso, G.; Mazzucco, S.; Rizzuto, N. Cerebral amyloidoses: molecular pathways and therapeutic challenges. Curr. Med. Chem. 2006, 13, 1903-1913.
2. Parchi, P.; Castellani, R.; Capellari, S.; Ghetti, B.; Young, K.; Chen, S.G.; Farlow, M.; Dickson, D.W.; Sima, A.A.; Trojanowski, J.Q.; Petersen, R.B.; Gambetti, P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 1996, 39, 767-778.
3. Zanusso, G.; Farinazzo, A.; Prelli, F.; Fiorini, M.; Gelati, M.; Ferrari, S.; Righetti, P.G.; Rizzuto, N.; Frangione, B.; Monaco, S. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J. Biol. Chem. 2004, 279, 38936-38942.
4. Zanusso, G.; Monaco, S. Molecular mechanisms of human prion diseases. Drug Discov. Today: Dis. Mech. 2005, 2, 511-518.
5. Zerr, I.; Pocchiari, M.; Collins, S.; Brandel, J.P.; de Pedro Cuesta, J.; Knights, R.S.; Berheimer, H.; Cardone, F.; Delasnerie-Lauprêtre, N.; Cuadrado Corrales, N. et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-jakob disease. Neurology 2000, 55, 811-815.
6. Zerr, I.; Kallenberg, K.; Summers, D.M.; Romero, C.; Taratuto, A.; Heinemann, U.; Breithaupt, M.; Varges, D.; Meissner, B.; Ladogana, A. et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009, 132, 2659-2668.
7. Otto, M.; Wiltfang, J.; Tumani, H.; Zerr, I.; Lantsch, M.; Kornhuber, J.; Weber, T.; Kretzschmar, H.A.; Poser, S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci. Lett. 1997, 225, 210-212.
8. Riemenschneider, M.; Wagenpfeil, S.; Vanderstichele, H.; Otto, M.; Wiltfang, J.; Kretzschmar, H.; Vanmechelen, E.; Forstl, H.; Kurz, A. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol. Psychiatr. 2003, 8, 343-347.
9. Sanchez-Juan, P.; Green, A.; Ladogana, A.; Cuadrado-Corrales, N.; Saanchez-Valle, R.; Mitrova, E.; Stoeck, K.; Sklaviadis, T.; Kulczycki, J.; Hess, K. et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006, 67, 637-643.
10. Green, A.; Sanchez-Juan, P.; Ladogana, A.; Cuadrado-Corrales, N.; Snchez-Valle, R.; Mitrov, E.; Stoeck, K.; Sklaviadis, T.; Kulczycki, J.; Heinemann, U. et al. CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur. J. Neurol. 2007, 14, 121-124.
11. Chohan, G.; Pennington, C.; Mackenzie, J.M.; Andrews, M.; Everington, D.; Will, R.G.; Knight, R.S.; Green, A.J. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J. Neurol. Neurosurg. Psychiat. 2010, 81, 1243-1248.
12. Hsich, G.; Kenney, K.; Gibbs, C.J.; Lee, K.H.; Harrington, M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 1996, 335, 924-930.
13. Zanusso, G.; Fiorini, M.; Farinazzo, A.; Gelati, M.; Benedetti, M.D.; Ferrari, S.; Dalla Libera, A.; Capaldi, S.; Monaco, H.L.; Rizzuto, N. et al. Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients. Neurology 2005, 64, 1618-1620.
14. Bersano, A.; Fiorini, M.; Allaria, S.; Zanusso, G.; Fasoli, E.; Gelati, M.; Monaco, H.; Squintani, G.; Monaco, S.; Nobile-Orazio, E. Detection of CSF 14-3-3 protein in Guillain-Barré syndrome. Neurology 2006, 67, 2211-2216.
15. Pennington, C.; Chohan, G.; Mackenzie, J.; Andrews, M.; Will, R.; Knight, R.; Green, A. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease. Neurosci. Lett. 2009, 455, 56-59.
16. Geschwind, M.D.; Shu, H.; Haman, A.; Sejvar, J.J.; Miller, B.L. Rapidly progressive dementia. Ann. Neurol. 2008, 64, 97-108.
17. Josephs, K.A.; Ahlskog, J.E.; Parisi, J.E.; Boeve, B.F.; Crum, B.A.; Giannini, C.; Petersen, R.C. Rapidly progressive neurodegenerative dementias. Arch. Neurol. 2009, 66, 201-207.
18. Baldeiras, I.E.; Ribeiro, M.H.; Pacheco, P.; Machado, A.; Santana, I.; Cunha, L.; Oliveira, C.R. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. J. Neurol. 2009, 256, 1540-1550.
19. Wang, G.R.; Gao, C.; Shi, Q.; Zhou, W.; Chen, J.M.; Dong, C.F.; Shi, S.; Wang, X.; Wei, Y.; Jiang, H.Y. et al. Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease. Am. J. Med. Sci. 2010, 340, 291-295.
20. Meiner, Z.; Kahana, E.; Baitcher, F.; Korczyn, A.D.; Chapman, J.; Cohen, O.S.; Milo, R.; Aharon-Perez, J.; Abramsky, O.; Gabizon, R.; Rosenmann, H. Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J. Neurol. 2011, 258, 255-262.
21. Otto, M.; Wiltfang, J.; Cepek, L.; Neumann, M.; Mollenhauer, B.; Steinacker, P.; Ciesielczyk, B.; Schulz-Schaeffer, W.; Kretzschmar, H.A.; Poser, S. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002, 58, 192-197.
22. Hansson, O.; Zetterberg, H.; Buchhave, P.; Londos, E.; Blennow, K.; Minthon, L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006, 5, 228-234.
23. Deisenhammer, F.; Egg, R.; Giovannoni, G.; Hemmer, B.; Petzold, A.; Sellebjerg, F.; Teunissen, C.; Tumani, H. EFNS guidelines on disease-specific CSF investigations. Eur. J. Neurol. 2009, 16, 760-770.
24. Van Everbroeck, B.; Quoilin, S.; Boons, J.; Martin, J.J.; Cras, P. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiat. 2003, 74, 1210-1214.
25. Gmitterová, K.; Heinemann, U.; Bodemer, M.; Krasnianski, A.; Meissner, B.; Kretzschmar, H.A.; Zerr, I. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiol. Aging 2009, 30, 1842-1850.
26. Castellani, R.J.; Colucci, M.; Xie, Z.; Zou, W.; Li, C.; Parchi, P.; Capellari, S.; Pastore, M.; Rahbar, M.H.; Chen, S.G.; Gambetti, P. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004, 63, 436-442.
27. Grossman, M.; Farmer, J.; Leight, S.; Work, M.; Moore, P.; van Deerlin, V.; Pratico, D.; Clark, C.M.; Coslett, H.B.; Chatterjee, A. et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann. Neurol. 2005, 57, 721-729.